Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes Read more
Verseau Launches with $50 Million to Develop First-in-Class Macrophage-Targeted Immunotherapies and Appoints George Golumbeski as Chairman of the Board Read more
Janssen Announces FDA Approval of STELARA (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis Read more
Biogen and Samsung Bioepis to Present Data for Infliximab and Adalimumab Biosimilars at United European Gastroenterology Week Read more
Alexion Receives FDA Approval For ULTOMIRIS (Ravulizumab-Cwvz) For Atypical Hemolytic Uremic Syndrome (AHUS) Read more
Continuous processing is the game changer to pharma and biotechs in 2020 – What you can learn at 4th CCP Summit? Read more
Merck Receives EU CHMP Positive Opinion for Investigational V920 Ebola Zaire Vaccine for Protection Against Ebola Virus Disease Read more